ÂÜÀòÂÒÂ×

Abby Buttermore currently serves as a Therapeutic Area Specialist in Neuro-Psychiatry at Bristol Myers Squibb, beginning in August 2024. Prior roles include Specialty Account Manager at Axsome Therapeutics, where Abby launched a new antidepressant, and Territory Business Manager at Alkermes, during which Abby represented a Long-Acting Injection for schizophrenia and launched a product for bipolar disorder, earning recognition in President's Club. Experience also includes being a Neuroscience Account Manager at Otsuka Pharmaceutical Companies, where Abby won President's Club in 2015, and various positions in sales and program coordination at companies such as Quintiles Commercial, Roche Diagnostics, Publicis Selling Solutions, and Pfizer. Abby holds a Bachelor of Arts degree in Individual and Family Studies from Kent State University, completed between 1994 and 1997.